Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.

Cognetti, F; Pinnarö, P; Ruggeri, E M; Carlini, P; Perrino, A; Impiombato, F A; Calabresi, F; Chilelli, M G; Giannarelli, D

Cognetti, F; Pinnarö, P; Ruggeri, E M; Carlini, P; Perrino, A; Impiombato, F A; Calabresi, F; Chilelli, M G; Giannarelli, D.

Affiliation

Cognetti F; Department of Medical Oncology I, National Cancer Institute Regina Elena, Rome, Italy.

J Clin Oncol ; 7(7): 829-37, 1989 Jul.

Article in En | MEDLINE | ID: mdl-2472469

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Head and Neck Neoplasms/drug therapy; Adult; Aged; Bleomycin/administration & dosage; Carcinoma, Squamous Cell/mortality; Cisplatin/administration & dosage; Clinical Trials as Topic; Combined Modality Therapy; Female; Fluorouracil/administration & dosage; Head and Neck Neoplasms/mortality; Humans; Male; Methotrexate/administration & dosage; Middle Aged; Premedication; Prognosis; Vincristine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Head and Neck Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1989 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links